HIV-1 Antigens in Plants for Vaccines
Author Information
Author(s): Ann Meyers, Ereck Chakauya, Enid Shephard, Fiona L. Tanzer, James Maclean, Alisson Lynch, Anna-Lise Williamson, Edward P. Rybicki
Primary Institution: University of Cape Town
Hypothesis
Can HIV-1 antigens be effectively expressed in plants to serve as potential subunit vaccines?
Conclusion
The study found that transient expression in plants yielded higher levels of HIV-1 proteins, which could boost immune responses in mice.
Supporting Evidence
- Transient expression yielded higher levels of p24 and p17/p24 proteins compared to Pr55Gag.
- The chloroplast-targeted p17/p24 protein significantly boosted immune responses in mice primed with a DNA vaccine.
- The study demonstrated the feasibility of using plants for producing vaccine-relevant HIV proteins.
Takeaway
Scientists are trying to use plants to make parts of the HIV virus that can help create a vaccine. They found that using a special method made more of these parts, which could help the body fight the virus better.
Methodology
The study used transient and transgenic expression systems in Nicotiana spp. to produce HIV-1 proteins and assessed their immunogenicity in mice.
Limitations
The yields of the proteins were below the expected economic threshold for vaccine production.
Participant Demographics
BALB/c mice were used for immunogenicity studies.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website